Suppr超能文献

含环丙烯酮的半胱氨酸蛋白酶抑制剂。合成及酶抑制活性。

Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.

作者信息

Ando R, Sakaki T, Morinaka Y, Takahashi C, Tamao Y, Yoshii N, Katayama S, Saito K, Tokuyama H, Isaka M, Nakamura E

机构信息

Pharmaceuticals Laboratory 1, Yokohama Research Center, Mitsubishi Chemical Corporation, Japan.

出版信息

Bioorg Med Chem. 1999 Apr;7(4):571-9. doi: 10.1016/s0968-0896(99)00007-3.

Abstract

By focusing on the amphiphilic properties of cyclopropenone (e.g. a good electrophile and a precursor for a stable 2pi-aromatic hydroxycyclopropenium cation), a new class of cysteine proteinase inhibitors containing a cyclopropenone moiety was designed. For the purpose of the present research, we needed to devise a new method to introduce a peptide-related moiety as a substituent on the cyclopropenone residue. We investigated the reaction of metalated cyclopropenone acetal derivatives (2, R2 = metal) with N-protected alpha-aminoaldehydes 4 to obtain the adduct 5, and succeeded in the preparation of highly potentiated cysteine proteinase inhibitors 8 after several steps transformations. They showed strong inhibitory activities only to cysteine proteinases such as calpain, papain, cathepsin B, and cathepsin L and not to serine (e.g. thrombin and cathepsin G) and aspartic proteinases (e.g. cathepsin D). Kinetic studies indicated that they are competitive inhibitors, and by the examinations of their inhibitory mechanism it became clear that they are reversible inhibitors.

摘要

通过关注环丙烯酮的两亲性质(例如,一种良好的亲电试剂和稳定的2π-芳香羟基环丙烯鎓阳离子的前体),设计了一类新的含环丙烯酮部分的半胱氨酸蛋白酶抑制剂。为了本研究的目的,我们需要设计一种新方法,将肽相关部分作为取代基引入环丙烯酮残基上。我们研究了金属化环丙烯酮缩醛衍生物(2,R2 = 金属)与N-保护的α-氨基醛4的反应以获得加合物5,并在经过几步转化后成功制备了高效的半胱氨酸蛋白酶抑制剂8。它们仅对诸如钙蛋白酶、木瓜蛋白酶、组织蛋白酶B和组织蛋白酶L等半胱氨酸蛋白酶表现出强抑制活性,而对丝氨酸蛋白酶(例如凝血酶和组织蛋白酶G)和天冬氨酸蛋白酶(例如组织蛋白酶D)没有抑制活性。动力学研究表明它们是竞争性抑制剂,并且通过对其抑制机制的研究清楚地表明它们是可逆抑制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验